Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Block

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Renal Care|April 3, 2025
Clinic-Based Animal-Assisted Intervention for Haemodialysis Patients' Treatment Adherence, Pain and Depression: An Interrupted Time Series AnalysisMeredith Stensland, Elizabeth Sanford, Adrian Elorriaga, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 19, 2010
A longitudinal study of uremic pruritus in hemodialysis patientsVandana S Mathur, Jill Lindberg, Michael Germain, et al.
Kidney International|October 1, 2015
Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease StudyUmut Selamet, Hocine Tighiouart, Mark J Sarnak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 19, 2013
Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) studyBritt Newsome, Joachim H Ix, Hocine Tighiouart, et al.
Clinical Kidney Journal|April 1, 2014
Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4Chek Ing Kiu Weber, Guillemette Duchateau-Nguyen, Corinne Solier, et al.
Journal of Nephrology|April 23, 2016
Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trialSung Min Ko, Chao Zhang, Zhengjia Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 7, 2017
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKDRakesh Malhotra, Ronit Katz, Andrew Hoofnagle, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022Meri Varkila, Maria Montez-Rath, Joshua Salomon, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Renal Care|April 3, 2025
Clinic-Based Animal-Assisted Intervention for Haemodialysis Patients' Treatment Adherence, Pain and Depression: An Interrupted Time Series AnalysisMeredith Stensland, Elizabeth Sanford, Adrian Elorriaga, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 19, 2010
A longitudinal study of uremic pruritus in hemodialysis patientsVandana S Mathur, Jill Lindberg, Michael Germain, et al.
Kidney International|October 1, 2015
Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease StudyUmut Selamet, Hocine Tighiouart, Mark J Sarnak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 19, 2013
Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) studyBritt Newsome, Joachim H Ix, Hocine Tighiouart, et al.
Clinical Kidney Journal|April 1, 2014
Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4Chek Ing Kiu Weber, Guillemette Duchateau-Nguyen, Corinne Solier, et al.
Journal of Nephrology|April 23, 2016
Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trialSung Min Ko, Chao Zhang, Zhengjia Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 7, 2017
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKDRakesh Malhotra, Ronit Katz, Andrew Hoofnagle, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2023
Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022Meri Varkila, Maria Montez-Rath, Joshua Salomon, et al.
Seminars in Dialysis|October 3, 2002
How should hyperphosphatemia be managed in dialysis patients?Geoffrey Block, Jaime Uribarri, Joseph A Coladonato, et al.
Clinical Pharmacology in Drug Development|January 25, 2019
Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and SafetyEdward Lee, John P Gibbs, Maurice G Emery, et al.
Pageof 3